Launch of generic Gralise (Once Daily Gabapentin tablets)

Released: 02/02/2024  

Launch of generic Gralise (Once Daily Gabapentin tablets) 

The generic formulation of Gralise, once daily Gabapentin tablets has been recently released. 

Gabapentin is indicated for the management of (PHN) postherpetic neuralgia. 

Gabapentin is not interchangeable with other gabapentin products because of differing pharmacokinetic profiles that affect the frequency of administration. 

Gabapentin once daily tablets are manufactured by Zydus Pharmaceuticals. 

Gabapentin once daily tablets are available in 300mg and 600mg tablets.